Sort
64,565 grants matching “drug discovery”
Center for Systems Neurogenetics of Addiction
$2,441,995Elissa J Chesler · Jackson Laboratory · P50 · FY2022 · DA
Mayo Clinic Breast Cancer SPORE
$2,438,534Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2017 · CA
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
$2,438,056France Carrier · University Of Maryland Baltimore · U19 · FY2022 · AI
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,437,189Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2008 · CA
Exploration of the TranslationalTherapeutic Potential of Stem Cell B
$2,437,089Howard Fine · Basic Sciences · Z01 · FY2007 · CA
AMP-AD Data Coordination Center
$2,437,076Anna K Greenwood · Sage Bionetworks · U24 · FY2021 · AG
HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,436,123Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,436,054Paul M. Lieberman · Wistar Institute · P01 · FY2023 · CA
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2017 · CA
Center of Catalytic Bioscanvenger Medical Defense Research II: Discovery, Formula
$2,435,232Douglas Mark Cerasoli · U.S. Army Medical Research Inst Chem Def · U54 · FY2012 · NS
COG NCTN Year 10 BIQSFP Supplement & Progress Report
$2,432,383Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
SPORE in Breast Cancer
$2,431,145Carlos L Arteaga · Vanderbilt University · P50 · FY2006 · CA
Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria
$2,430,648Michael T Ferdig · University Of Notre Dame · P01 · FY2024 · AI
Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase I
$2,429,633Roberta Diaz Brinton · University Of Southern California · UF1 · FY2013 · AG
Central Hub for Kidney Precision Medicine - Administrative Core
$2,429,128Jonathan Himmelfarb · University Of Washington · U2C · FY2020 · DK
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
$2,428,649James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2020 · AI
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
$2,428,494Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2025 · AI
MRI: Development of a next-generation MALDI ion mobility mass spectrometry platform for molecular imaging and training
$2,426,379Richard Caprioli · Vanderbilt University · · FY2018 · ENG
Calcium Signaling &Prefrontal Deficits in Schizophrenia
$2,425,320Yale University · P50 · FY2004 · MH
Washington University PDX Development and Trial Center
$2,424,750Ramaswamy Govindan · Washington University · U54 · FY2017 · CA
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,423,115Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2016 · CA
Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease
$2,423,010Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,420,381Paul M. Lieberman · Wistar Institute · P01 · FY2025 · CA
Modeling Neurodegenerative Disease Manifestations in Human Enteric Neurons
$2,420,000Faranak Fattahi · University Of California, San Francisco · DP2 · FY2019 · NS